Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,764 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06457386Recruiting
Echocardiogram vs no echocardiogram for low-risk Staph blood infection
This study compares two approaches for people with a blood infection caused by Staphylococcus aureus who are at low risk for heart infection (VIRSTA score <3). Half of the participants will get a standard echocardiogram (heart ultrasound), and the other half will not, to see if skipping the test is safe and effective.
ParisAges 18 years+ - NCT06458062Recruiting
Pocket colposcopy for women with positive HPV test
This study tests a new, smaller device called a pocket colposcope to look at the cervix (the opening of the womb) in women who have had a positive HPV test. The goal is to see if this simpler tool can help find cell changes that might lead to cancer, so you can get treatment sooner.
NairobiAges 25 years+ - NCT06463912Recruiting
Hepatitis C screening for people who inject drugs in Armenia
This study is testing a screening program for hepatitis C among people who inject drugs in Armenia, Colombia. It aims to find and help those who may have the virus but don't know it.
Armenia, Quindío DepartmentAges 18–100 - NCT06476171Recruiting
Blood test study for heart surgery patients
This study looks at blood test results from people having heart surgery with a heart-lung machine. It will help doctors understand and improve the use of these tests.
MoscowAges 18–80 - NCT06476210RecruitingPhase 4
New drug combo for drug-resistant tuberculosis
This trial tests a three-drug combination (bedaquiline, delamanid, and linezolid) to see if it's safe and works well for people with multi-drug resistant or rifampicin-resistant tuberculosis. It may offer a new treatment option if standard drugs aren't working.
Hefei, AnhuiAges 18 years+ - NCT06482138Recruiting
Why smell may change after COVID-19: a nose tissue study
This study looks at why some people lose or change their sense of smell after COVID-19. Researchers will take a tiny sample of tissue from your nose to study the cells and molecules involved.
Brussels, Brussels CapitalAges 18–70 - NCT06482463Recruiting
D-lactate test for meningitis in patients with a brain drain
This study checks if a substance called D-lactate in the fluid around your brain can help diagnose meningitis that develops in the hospital after a brain drain (ventriculostomy). It aims to improve diagnosis.
ToulouseAges 18 years+ - NCT06230367Recruiting
Text program for HIV prevention for young guys who like guys
This trial tests a text-messaging program to help young guys who have sex with guys stay HIV-negative. It's designed for teens and young adults who own a cell phone and can take a quick HIV test at home.
San Clemente, CaliforniaAges 13–22 - NCT06250504RecruitingPhase 3
HIV prevention study for young adults
This study tests a long-acting HIV prevention shot (Cabotegravir) or a vaginal ring (DapiRing) along with sexual health services for young people. It aims to find the best way to prevent HIV and support overall health.
Somkele, KwaZulu-NatalAges 15–30 - NCT06488118Recruiting
Lung response to inhaled immune stimulant in healthy and asthma
This study tests how the lungs react to breathing in a weak immune-stimulating drug (R848). It includes healthy volunteers and people with mild to moderate asthma to see differences in airway responses.
Cambridge, CambridgeshireAges 18–60 - NCT06498414RecruitingPhase 2/Phase 3
Shorter and safer treatment for latent TB
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
CotonouAges 5 years+ - NCT06501781Recruiting
PUSH: Helping People with HIV and Substance Use
This study tests if a program that encourages positive activities (behavioral activation) can help people with HIV or on PrEP who also use substances improve their health. It focuses on those receiving long-acting injectable medications for HIV prevention or treatment.
Washington D.C., District of ColumbiaAges 18–88 - NCT06504485Recruiting
Study of bulevirtide for chronic hepatitis B and D
This trial tests a drug called bulevirtide for people with chronic hepatitis B and D (HDV) co-infection. It looks at how the immune system and virus respond to treatment.
MilanAges 18 years+ - NCT06505512Recruiting
Belly infection and kidney health ultrasound study
This study uses ultrasound to look at your belly organs and kidney blood flow in people with serious belly infections and sepsis. It may help doctors understand how infection affects the kidneys.
Zhangzhou, FujianAges 14–85 - NCT06507917Recruiting
HPV self-screening vs doctor screening for anal cancer in HIV
This study compares self-sampling (doing your own swab) to a healthcare professional doing the swab for HPV, a virus that can lead to anal cancer. It is for people with HIV on Réunion Island.
Saint-DenisAges 30 years+ - NCT06508502Recruiting
Pancreatitis Severity and Gut Bacteria Study
This study looks at how the bacteria in your gut (microbiome) might affect the severity of a first-time acute pancreatitis attack. It aims to see if certain gut bacteria can predict how serious the illness will be, which could help doctors treat patients better.
Göttingen, Lower SaxonyAges 18 years+ - NCT06508749RecruitingPhase 1/Phase 2
Testing antibody therapy for HIV in children
This study tests whether a combination of special antibodies (bNAbs) can help control HIV without daily medication. It involves several steps and is for children who are already doing well on ART.
FrancistownAges 6 months–25 years - NCT06509113Recruiting
Online HIV Stigma Training for Nursing Students
This online study tests a training program to help nursing students in Iran reduce stigma toward people living with HIV. It is only open to 3rd- and 4th-year nursing students at Kerman Medical University.
KermanAges 18 years+ - NCT06510426RecruitingPhase 2
Early Interferon-beta for West Nile Virus
This trial tests if giving early treatment with interferon-beta can help patients with West Nile virus (WNV) infection, especially those at higher risk of serious illness. It includes older adults, people with severe neurological symptoms, and those with weakened immune systems.
Tel AvivAges 18 years+ - NCT06513156Recruiting
Care support for hospitalized patients with drug-related infections
This study is for people who are in the hospital with a serious infection caused by injection drug use. It aims to provide better care and support while you are in the hospital and after you leave.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06514547RecruitingPhase 4
Vaccine response and aging in people with HIV
This study is for people living with HIV who are 18 or older and on HIV medication. Researchers want to learn how the immune system and vaccine response change as people age, and will give a pneumococcal (pneumonia) vaccine to study that.
Minneapolis, MinnesotaAges 18 years+ - NCT06519032Recruiting
AI Tool for Faster Bacterial ID in Lung Tests
This trial is testing a new AI tool that quickly identifies bacteria from your AFB test sample. If your doctor ordered this test, you can help see if the AI works well.
Suita, OsakaAges Any age - NCT06522256Recruiting
HPV and anal cancer risk 10 years later
This study looks at HPV (the virus that can cause anal cancer) and checks if certain types of high-risk HPV are linked to abnormal cells or cancer in the anus, 10 years after joining the IPERGAY trial. It helps researchers understand long-term risks.
LyonAges 18 years+ - NCT06527664Recruiting
Custom hip implant for failed arthritis treatments
This trial tests a custom-made hip socket implant for people who have had a failed hip replacement or arthritis treatment. It aims to see if a personalized implant can provide a better solution.
BolognaAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,764 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.